Vimarsana
Biggest News Aggregation in the World

Page 6 - Aim Leukemia News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aim Leukemia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aim Leukemia Today - Breaking & Trending Today

Curis Announces FDA Partial Clinical Hold for TakeAim Leukemia Study of Emavusertib (CA-4948) - Vimarsana News

Curis Announces FDA Partial Clinical Hold for TakeAim Leukemia Study of Emavusertib (CA-4948)

/PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today...

Curis Announces Gastroenterolo - GuruFocus.com - Vimarsana News

Curis Announces Gastroenterolo - GuruFocus.com

GuruFocus Article or News written by PRNewswire and the topic is about:

Curis Reports Fourth Quarter and Year End 2021 Financial Results - Vimarsana News

Curis Reports Fourth Quarter and Year End 2021 Financial Results

/PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today...

Curis Reports Fourth Quarter and Year End 2021 Financial Results - Vimarsana News

Curis Reports Fourth Quarter and Year End 2021 Financial Results

/PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today...